Individualized workup - A new approach to the biochemical diagnosis of acute attacks of neuroporphyria

Physiological Research

Volumn 55, Issue SUPPL. 2, 2006, Pages

  Schoenfeld, Nili ^a,b   Mamet, R ^a  

^a RABIN MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

Acute attack; Biochemical diagnosis; Porphobilinogen (PBG); Porphyria

Indexed keywords

PORPHOBILINOGEN;

ACUTE INTERMITTENT PORPHYRIA; ADOLESCENT; ADULT; ARTICLE; CASE REPORT; COMPARATIVE STUDY; FEMALE; HUMAN; MALE; MIDDLE AGED; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; URINE;

ADOLESCENT; ADULT; FEMALE; HUMANS; MALE; MIDDLE AGED; PORPHOBILINOGEN; PORPHYRIA, ACUTE INTERMITTENT; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY;

EID: 33847130105     PISSN: 08628408     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. ACKNER B, COOPER JW, GRAY CH, KELLY M, NICHOLSON DC: Excretion of porphobilinogen and 5-aminolaevulinic acid in acute porphyria. Lancet 1: 1256-1260, 1961.
2. ANDERSON KE. The porphyrias. In: Cecil's Textbook of medicine. L GOLDMAN, D AUSIELLO (eds): 22 ed Philadelphia, PA: WB Saunders Co., 2004, pp: 1292-1300.
3. BERKO G, DURKO I: A new possibility for the demonstration of amino laevulinic acid in urine on the basis of Mauzerall Granick method. Clin Chim Acta 37: 443-447, 1972.
4. BUTTERY JE, STUART S: Measurement of porphobilinogen in urine by a simple resin method with use of a surrogate standard. Clin Chem 37: 2133-2136, 1991.
5. DESNICK RJ: The Porphyrias In: Harrison's principles of internal medicine. DL KASPER, AS FAUCI, E BROUNWALD, SL HAUSER, JL JAMSON, TR HARRISON, (eds. 16 ed New York: McGraw Hill 2005, chapter 337.
6. EUROPEAN PORPHYRIA INITIATIVE (EPI). http://www.porphyria-europe.com, 2005.
7. GOLDBERG A: Renal clearance of endogenous porphobilinogen in man. Lancet 267: 1095-1097, 1954.
8. KOSTRZEWSKA E, GREGOR A: Increased activity of porphobilinogen deaminase in erythrocytes during attacks of acute intermittent porphyria. Ann Clin Res 18: 195-198, 1986.
9. LAMON JM: Clinical Aspects of porphyrin measurement other than lead poisoning. Clin Chem 23: 260-263, 1977.
10. LONG C, SMYTH SJ, WOOLF J, MURPHY GM, FINLAY AY, NEWCOMBE RG, ELDER GH: Detection of latent variegate porphyria by fluorescence emission spectroscopy of plasma. Br J Dermatol 129: 9-13, 1993.
11. MAGNUSSEN CR, LEVINE JB, DOHERTY JM, CHEESMAN MO, TSCHUDY DP. A red cell enzyme method for diagnosis of acute intermittent porphyria. Blood 44: 857-868, 1974.
12. MAMET R, SZTERN M, RACHMEL A, STAHL B, FLUSSER D, SCHOENFELD N: Lead poisoning: A new biochemical perspective on the differentiation between acquired and hereditary neuroporphyria (Technical Brief) Clin Chem 47: 1710-1713, 2001.
13. MEDLINEPLUS, GRECO FA: www.nlm.nih.gov/medlineplus/ency/article/003596. htm, 2004.
14. MUSTAJOKI P, NORDMANN Y: Early administration of heme arginate for acute porphyria attacks. Arch Intern Med 153: 2004-2008, 1993.
15. SCHOENFELD N, MAMET R, DOTAN I, SZTERN M, LEVO Y, ADERKA D: Relation between uroporphyrin excretion, acute attack of hereditary coproporphyria and successful treatment with haem arginate. Clin Sci; 88: 365-369, 1995.
16. TEFFERI A, COGAN JP, SOLBERG LA Jr: Acute porphyrias: diagnosis and management. Mayo Clin Proc 69: 991-995, 1994.
17. VERSTRAETEN L, LEDOUX MC, MOOS B, CALLEBOUT B, CORNU G, HASSOUN A: Interference of Tienam in colorimetric determination of 5-aminolevulinic acid and porphobilinogen in serum and urine. Clin Chem 38: 2557-2558, 1992.